Repligen(DE:RGN)
€157.05-0.70 (-0.44%)
DE:RGN
Repligen stock forecast
€157.05
At close:-0.70 (-0.44%)
Repligen (RGN) Stock Forecast & Price Target
2 Followers
RGN Analyst Ratings
Strong Buy
7Buy1Hold0Sell
Based on 8 analysts giving stock ratings to Repligen in the past 3 months
RGN Stock 12 Month Forecast
Average Price Target
€188.28▲(19.88% Upside)Based on 8 Wall Street analysts offering 12 month price targets for Repligen in the last 3 months. The average price target is EUR 188.28 with a high forecast of EUR 210.41 and a low forecast of EUR 161.16. The average price target represents a 19.88% change from the last price of EUR 157.05.
Past 12 Months12 Month ForecastJan2026Oct2026
High€210.41
Average€188.28
Low€161.16
Highest Price TargetHighest€210.41Average Price Target€188.28Lowest Price TargetLowest€161.16
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Daniel Arias | Stifel Nicolaus | €185.34 | buy | 18.01%Upside | Reiterated | 11/11/26 | ||
| Dan Leonard | RBC Capital | €179.07 | buy | 14.02%Upside | Reiterated | 11/01/26 | ||
| Casey Woodring | J.P. Morgan | €179.07→€183.55 | buy | 16.87%Upside | Reiterated | 10/29/26 | ||
| Kyle Mikson CFA | Canaccord Genuity | €161.16 | hold | 2.62%Upside | Reiterated | 10/28/26 | ||
| Luke Sergott | Barclays | €201.45 | buy | 28.27%Upside | Reiterated | 10/28/26 | ||
| Doug Schenkel | UBS | €210.41 | buy | 33.97%Upside | Reiterated | 10/28/26 | ||
| Paul Knight | KeyBanc | €196.98 | buy | 25.42%Upside | Reiterated | 10/28/26 | ||
| Matt Hewitt | Craig-Hallum | ― | buy | ― | Reiterated | 09/25/26 | ||
| Matt Larew | William Blair | ― | buy | ― | Reiterated | 07/28/26 | ||
| Brendan Smith | TD Cowen | €179.07 | buy | 14.02%Upside | Reiterated | 07/28/26 | ||
| Robert Wasserman | StoneX | €165.64 | buy | 5.47%Upside | Upgraded | 07/07/26 | ||
| Daniel Markowitz CFA | Evercore ISI | €134.30→€143.26 | buy | -8.78%Downside | Reiterated | 07/06/26 | ||
| Yessica Sanchez Gudino | HSBC | €152.21→€134.30 | buy | -14.48%Downside | Reiterated | 06/03/26 | ||
| Michael Polark | Wolfe Research | €129.83 | buy | -17.33%Downside | Initiated | 06/01/26 | ||
 Unknown AnalystNot Ranked | Guggenheim | ― | hold | ― | Reiterated | 05/07/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Daniel AriasStifel Nicolaus | BuyReiterated€185.34 | 11/11/26 | 18.01%Upside | ||
| Dan LeonardRBC Capital | BuyReiterated€179.07 | 11/01/26 | 14.02%Upside | ||
| Casey WoodringJ.P. Morgan | BuyReiterated€179.07→€183.55 | 10/29/26 | 16.87%Upside | ||
| Kyle Mikson CFACanaccord Genuity | HoldReiterated€161.16 | 10/28/26 | 2.62%Upside | ||
| Luke SergottBarclays | BuyReiterated€201.45 | 10/28/26 | 28.27%Upside | ||
| Doug SchenkelUBS | BuyReiterated€210.41 | 10/28/26 | 33.97%Upside | ||
| Paul KnightKeyBanc | BuyReiterated€196.98 | 10/28/26 | 25.42%Upside | ||
| Matt HewittCraig-Hallum | BuyReiterated | 09/25/26 | ― | ||
| Matt LarewWilliam Blair | BuyReiterated | 07/28/26 | ― | ||
| Brendan SmithTD Cowen | BuyReiterated€179.07 | 07/28/26 | 14.02%Upside | ||
| Robert WassermanStoneX | BuyUpgraded€165.64 | 07/07/26 | 5.47%Upside | ||
| Daniel Markowitz CFAEvercore ISI | BuyReiterated€134.30→€143.26 | 07/06/26 | -8.78%Downside | ||
| Yessica Sanchez GudinoHSBC | BuyReiterated€152.21→€134.30 | 06/03/26 | -14.48%Downside | ||
| Michael PolarkWolfe Research | BuyInitiated€129.83 | 06/01/26 | -17.33%Downside | ||
| Unknown AnalystGuggenheimNot Ranked | HoldReiterated | 05/07/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Repligen
3 Months
Success Rate8/10 ratings generated profit
80%
Average Return
+9.87%
Copying Luke Sergott's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +9.87% per trade.
1 Year
Success Rate10/10 ratings generated profit
100%
Average Return
+21.86%
Copying Luke Sergott's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.86% per trade.
2 Years
Success Rate11/11 ratings generated profit
100%
Average Return
+30.03%
Copying Brandon Couillard's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +30.03% per trade.
RGN Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 0 | 0 | 0 | 0 |
| Buy | 21 | 18 | 17 | 13 | 15 |
| Hold | 5 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 30 | 20 | 20 | 16 | 18 |
In the current month, RGN has received 15 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. RGN average Analyst price target in the past 3 months is 188.28.
RGN Financial Forecast
High€0.48
Consensus€0.47
Low€0.44
RGN Earnings Forecast
Next quarter’s earnings estimate for RGN is EUR 0.47 with a range of EUR 0.44 to EUR 0.48. The previous quarter’s EPS was EUR 0.47. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€218M
Consensus€214M
Low€213M
RGN Sales Forecast
Next quarter’s sales forecast for RGN is EUR 214.16M with a range of EUR 213.07M to EUR 218.31M. The previous quarter’s sales results were EUR 185.98M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
RGN Stock Forecast FAQ
What is DE:RGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Repligen’s 12-month average price target is €188.28.
What is DE:RGN’s upside potential, based on the analysts’ average price target?
Repligen has 19.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Repligen a Buy, Sell or Hold?
Repligen has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
What is Repligen’s share price target?
The average share price target for Repligen is €188.28. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €210.41, and the lowest forecast is €161.16. The average share price target represents a 19.88% increase from the current price of €157.05.
What do analysts say about Repligen?
Repligen’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of Repligen?
To buy shares of DE:RGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
